Autopsy report · NCT03436745
The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females
Cause of deathSlow enrollment
“Slow/insufficient accrual”
Life of this trial
- Registered 11 months before it started.
- Ran for about 5 years before it stopped.
- 12 participants enrolled.
- Results were posted on the registry 1 year after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- National Cancer Institute (NCI)
- Sponsor type
- US National Institutes of Health
- Conditions
- Prostatic Neoplasms
- Interventions
- Zolpidem; ECG
- Participants
- 12
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Regorafenib + Panitumumab for Colorectal Cancers
“Slow accrual”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.